Expression of the candidate reference genes in whole blood of multiple sclerosis (MS) subjects is compared to age and gender matched control subjects using the ΔΔCt Method and the Comparative Ct Method.
Table 2 Comparison of the foramen diameter in patients with multiple sclerosis and control subjects Foramen diameter Right Left Sum Patients with multiple sclerosis (mm) 6.3 ± 1.6 5.6 ± 1.3 11.9 ± 2.3 Controls (mm) 7.0 ± 1.4 6.0 ± 1.3 13.0 ± 2.1 p value* 0.020 0.089 0.009 Data are means ± standard deviation *Student t test.
The results of contrast sensitivity measurements show that there is a significant difference in the mean contrast sensitivity between group of patients after optic neuritis in multiple sclerosis and healthy subjects (Table 1).
To compare quadriceps fatigability during maximal concentric contractions in persons with multiple sclerosis (MS) and healthy subjects.
Cattaneo D, Ferrarin M, Frasson W, Casiraghi A. Head control: volitional aspects of rehabilitation training in patients with multiple sclerosis compared with healthy subjects.
Objective: To compare whole-body fat mass and fat-free mass (FFM) in ambulatory patients with multiple sclerosis (MS) and control subjects without MS. Design: Nonrandomized controlled trial or cross-sectional study.
We sought to evaluate the effect of dalfampridine-ER tablets (prolonged-release fampridine in Europe) on health utility in patients with multiple sclerosis (MS) by mapping subjects' individual item scores from the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) onto the Euroqol 5-Dimension (EQ-5D) health utility index.
Two studies using 31P-magnetic resonance spectroscopy (MRS) reported enhanced phosphocreatine (PCr) levels in normal appearing white matter (NAWM) of subjects with multiple sclerosis (MS), but this finding could not be properly explained.
Second, we assessed this issue by asking subjects about multiple sclerosis in their relatives, a disease that is also severe but unrelated to lung cancer and found broadly similar numbers of relatives with multiple sclerosis in both probands and controls, even slightly more in the families of controls.
One subject (subject 10) had multiple sclerosis (MS) and was non-ambulatory with internuclear ophthalmoplegia and neurological deficits associated with cranial nerves II, III, IV and VI, but no history of pneumonia.
